In the challenging landscape of cancer treatment, Carfilnat Injection, a trusted brand of Carfilzomib, has emerged as a beacon of innovation, hope, and targeted action. Especially formulated for patients battling relapsed or refractory multiple myeloma, Carfilnat represents a significant advancement in proteasome inhibition — a mechanism designed to disrupt cancer cell survival at its... Carfilnat Injection: A Precision-Driven Breakthrough in Multiple Myeloma Therapy